NY-THE-BODY-SHOP
11.5.2022 17:02:10 CEST | Business Wire | Press release
Millions of young people are missing from public life. With the climate crisis, global conflict and generational inequalities running rampant, the inputs, perspectives and representation of youth are needed more than ever.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220509005499/en/
Almost half the world's population is under 30. Yet, they make up only 2.6% of parliamentarians around the world**. The average age of a world leader is currently 62***. Of all the parliaments in the world, 37% do not have a single Member of Parliament (MP) under age 30** and less than 1% of these young MPs are women.
Young people have the right to be included in political decisions that affect them, however, numerous barriers prevent their participation. The Body Shop and the Office of the United Nations Secretary-General's Envoy on Youth are collaborating to change this through the global Be Seen Be Heard campaign, which seeks to create long-term structural changes to decision-making to be more inclusive of young people.
It is launched today with the release of a research piece titled ‘ Be Seen Be Heard: Understanding young people’s political participation’.
The research includes the largest-ever survey carried out by The Body Shop, covering 26 countries with 27,043 respondents. It found that 82% of people surveyed agree that political systems need drastic reform to be fit for the future.
Two in three people also agree that the age balance in politics is wrong, with 8 in 10 people of all ages believing the ideal voting age (the age when someone can first vote) is 16 to 18, despite that in most countries the voting age is 18 or over. A third of those under age 30 surveyed would consider running for office versus only a fifth of those over age 30. People across all age groups agree that more opportunities for younger people to have a say in policy development and/or change would make political systems better.
David Boynton, CEO of The Body Shop says, “Our position is clear. The world’s problems cannot be solved by the same people making the same choices. The majority of young people are positive about the future, and we need to hear their views and ideas inside the halls of power. We will use our global reach to galvanise awareness and support, as we have in the past.”
Jayathma Wickramanayake, the United Nations Secretary-General’s Envoy on Youth says, “The intergenerational gap in power, influence and trust constitutes one of the biggest challenges of our time. Participation is a right, and a lack of youth representation where decisions are made contributes to a growing mistrust towards political institutions and a sense of alienation from elected leaders, caused by policies that do not reflect the priorities of youth, mirror their concerns or speak their language. This campaign is an opportunity to change that.”
The report suggests that young people’s participation in public decision-making could be improved long-term by a number of initiatives including; lowering voting ages, increasing formal youth representation, removing barriers for young people to participate in public decision-making, simplifying registration for first-time voters and improving young people’s leadership skills.
The campaign is launching globally in May 2022 and will run until mid-2025, driven by action in over 2,600 Body Shop stores in 75 countries, across six continents.
More information here.
Ends
** https://www.ipu.org/our-impact/youth-empowerment/data-youth-participation
*** REIGN Dataset | REIGN (oefdatascience.github.io)
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005499/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
